Position in EBS
as of Jun 30, 2026
· filed Jul 14, 2026
Position Value
$1,390,066
+$1,216,891 QoQ
Shares Held
165,879
+1083.9% QoQ
Ownership
0.324%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#42
of 194 holders
Holding Since
Sep 2022
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in EBS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Y-Intercept (Hong Kong) Ltd holds $54,645,005 across 16 Drug Manufacturers - Specialty & Generic names. EBS ranks #12 (2.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
147,055 | $10,567,372 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
14,271 | $7,732,455 | |
| 3 | HIMS |
Hims & Hers Health, Inc.
|
190,145 | $6,592,327 | |
| 4 | INDV |
Indivior Pharmaceuticals, Inc.
|
136,725 | $5,609,826 | |
| 5 | VTRS |
Viatris Inc
|
331,130 | $5,258,344 | |
| 6 | PRGO |
PERRIGO Co plc
|
346,586 | $3,601,028 | |
| 7 | XERS |
Xeris Biopharma Holdings, Inc.
|
411,346 | $3,257,860 | |
| 8 | ANIP |
Ani Pharmaceuticals Inc
|
34,505 | $2,856,323 |
All Filings in EBS
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,390,066 | 165,879 | Shares | Sole | 2026-07-14 | |
| 2025-12-31 | $173,175 | 14,011 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $155,126 | 17,588 | Shares | Sole | 2025-10-31 | |
| 2025-03-31 | $461,826 | 95,026 | Shares | Sole | 2025-05-06 | |
| 2024-06-30 | $110,709 | 16,233 | Shares | Sole | 2024-08-14 | |
| 2023-09-30 | $256,230 | 75,362 | Shares | Sole | 2023-11-14 | |
| 2022-12-31 | $283,546 | 24,009 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $318,586 | 15,178 | Shares | Sole | 2023-02-14 | |
| No filing history on record for this holder in this stock. | ||||||